Among significant research news last week, US CNS specialist Axsome Therapeutics released new Phase III data on its recently ...

The US President Donald Trump began his second term with a series of directives targeting the US National Institutes of ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended three novel medicines for approval at its ...

Massachusetts, USA-based start-up Magnet Biomedicine, which is advancing molecular glue discovery with rational selection and ...

Medicare Part D spending for 10 selected diabetes drugs in the USA totaled $35.8 billion in 2023, an increase of 364% from ...

US health officials are reportedly reexamining a $590 million agreement awarded to Moderna (Nasdaq: MRNA) for the development ...

Israeli drug manufacturer Teva Pharmaceutical Industries has resumed the deliveries of the scarce epilepsy drug Finlepsin ...

Sino American biotech BeiGene has announced financial results and corporate updates from the fourth quarter and full year ...

South Korean vaccine maker SK bioscience today revealed that it has received prior notification from the Pan American Health ...

Kallyope’s latest obesity drug trial results show modest weight-loss effects that lag behind competing therapies in the ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved an mRNA respiratory syncytial virus (RSV) ...

Japanese biopharma Nxera Pharma has announced two deals in a single day with partners that will commercialize its products in ...